What does REGN mean in NASDAQ SYMBOLS
REGN is the short form of Regeneron Pharmaceuticals, Incorporated. It is an American biotechnology company specialized in the development and commercialization of medicines for certain serious medical conditions. Founded in 1988, Regeneron has become one of the leading biotechnology companies in the world with a number of breakthrough therapies now approved and marketed for several conditions that previously had few or no treatments available. Regeneron’s three most advanced products include Eylea (aflibercept) injection; Dupixent (dupilumab); and Praluent (alirocumab).
REGN meaning in NASDAQ Symbols in Business
REGN mostly used in an acronym NASDAQ Symbols in Category Business that means Regeneron Phrmaceuticals, Incorporated
Shorthand: REGN,
Full Form: Regeneron Phrmaceuticals, Incorporated
For more information of "Regeneron Phrmaceuticals, Incorporated", see the section below.
What does REGN Stand for?
REGN stands for Regeneron Pharmaceuticals, Incorporated, a biopharmaceutical company based in Tarrytown, New York. Founded in 1988 by Leonard Schleifer M.D., Ph.D., and George Yancopoulos M.D., Ph.D., Regeneron develops new drugs to treat serious medical conditions including cardiovascular disease, allergic diseases, eye disorders, cancer, pain management, inflammation and infectious diseases. The company is well-known for its innovative approach to drug discovery where it combines internal research capabilities with collaborations with independent scientists from some of the world's leading academic institutions and research organizations to find promising new drugs targeting specific biochemical actions or pathways that affect illness or disease processes in humans.
REGN Meaning in Business
In business terms, REGN stands for Render 340B Solutions which offers a comprehensive suite of technology solutions that enable healthcare providers to optimize their pharmaceutical cost savings through the 340B Drug Discount Program established by Section 340B of the Public Health Service Act enacted by Congress in 1992. The program provides discounted outpatient prescription drugs to eligible healthcare organizations such as federally qualified health centers (FQHCs), rural health clinics (RHCs), free clinics (FCs), Ryan White HIV/AIDS clinics (RHACs), disproportionate share hospitals (DSH) among others so they can better leverage drug pricing discounts provided through pharmaceutical manufacturers agreements with large group purchasing organizations (GPOs). With access to these discount prices when purchasing outpatient prescription drugs directly from pharmaceutical manufacturers or indirectly through third-party vendors participating in the program under contract with pharmaceutical manufacturers, eligible entities can reduce their costs associated with medications purchased on behalf of members or patients while ensuring compliance with all applicable federal laws governing this program.
Essential Questions and Answers on Regeneron Phrmaceuticals, Incorporated in "BUSINESS»NASDAQ"
What is Regeneron Pharmaceuticals, Inc?
Regeneron is a biotechnology company that discovers and develops medicines for people with serious diseases. The company focuses on treatments for cancers, eye diseases, inflammation and other conditions. With headquarters in Tarrytown, New York, Regeneron has research and development facilities across the United States and Europe.
How long have Regeneron been in business?
Since 1988 when Dr. George Yancopoulos co-founded the company. Throughout its many years of operation, the company has created a range of innovative treatments and therapies for different medical conditions.
What kind of products does Regeneron manufacture?
Regeneron manufactures a range of therapeutic products used to treat many diseases such as heart disease, cancer, inflammatory bowel disease, arthritis and more. The company also produces treatments to improve vision in patients with various ocular disorders like macular degeneration or diabetic retinopathy.
Does Generon conduct clinical trials?
Yes, Regeneron regularly participates in clinical trials to evaluate new therapeutic products or potential changes to existing treatments. The results from these trials help determine if a product is safe and effective enough for commercial sale.
Does Regeneron work with partners?
Yes, the company works in collaboration with pharmaceutical partners to develop new therapeutics and expand access to potentially life-saving treatments worldwide. They strive to make their medicines available as soon as possible so people can benefit from them regardless of where they live or what their financial situation may be.
What types of research does Regeneron conduct?
As one of the leading biotechnology companies in the world, Regeneron conducts cutting-edge research on a variety of topics related to health science including genetics and molecular biology. Their scientists work hard everyday striving for innovative advances in medical treatment that will improve the quality of life for individuals all around the globe.
Are there any current job openings at Regeneroni?
Yes! There are always positions available at our talented teams around the globe – from scientists conducting ground breaking research to administrators managing finance departments across multiple countries. To view current job openings visit our website at www.regenerpharmaceuticalsincorporated.com/jobs.
What safety measures does Regeroen follow during production processes?
Safety is always paramount at Regeroen which is why we strictly follow all relevant regulatory standards during production processes while employing close monitoring procedures throughout each step of the manufacturing cycle - from sourcing materials through distribution activities - ensuring complete compliance with applicable laws & commandments at all times.
Final Words:
In conclusion, REGN stands for Regeneron Pharmaceuticals, Incorporated which is a biopharmaceutical company specializing in developing revolutionary medicines to treat serious medical conditions primarily focusing on cardiovascular disease, allergies allergy related diseases like asthma & eczema , dermatology related ailments like psoriasis & dermatitis , eye disorders like macular degeneration & retinopathy ; cancer; pain management; inflammation; and infectious diseases among other therapeutic areas .The company's innovative approach combines internal research capabilities along with collaborations with independent scientists from leading academic institutions to discover extraordinary new drugs targeting specific biochemical actions or pathways that effect illnesses & diseases affecting human beings today . In addition , REGN also stands Render 340B Solutions which provides healthcare providers access to discounted outpatient prescription drugs helping them reduce costs associated with medications purchased on behalf of members & patients while following all pertinent rules/regulations governed by this particular program .